Business Description
Chempartner Pharmatech Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000Y27
Share Class Description:
SZSE:300149: Class ACompare
Compare
Traded in other countries / regions
300149.China IPO Date
2010-12-22Description
Chempartner Pharmatech Co Ltd is engaged in the research, development, production, and operation of prebiotics, micro-ecological medical, and biopharmaceuticals.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.54 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | -0.69 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.69 | |||||
| Beneish M-Score | -5.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.4 | |||||
| 3-Year FCF Growth Rate | 0.3 | |||||
| 3-Year Book Growth Rate | -15.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.23 | |||||
| 9-Day RSI | 34.08 | |||||
| 14-Day RSI | 40.26 | |||||
| 6-1 Month Momentum % | -47.03 | |||||
| 12-1 Month Momentum % | -42.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | |||||
| Quick Ratio | 1.7 | |||||
| Cash Ratio | 0.86 | |||||
| Days Inventory | 17.1 | |||||
| Days Sales Outstanding | 95.89 | |||||
| Days Payable | 24.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 12.75 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 22.69 | |||||
| Operating Margin % | -5.36 | |||||
| Net Margin % | -81.94 | |||||
| FCF Margin % | 4.67 | |||||
| ROE % | -45.67 | |||||
| ROA % | -29.85 | |||||
| ROIC % | -2.32 | |||||
| ROC (Joel Greenblatt) % | -88.46 | |||||
| ROCE % | -35.14 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.15 | |||||
| PB Ratio | 1.68 | |||||
| Price-to-Tangible-Book | 1.94 | |||||
| Price-to-Free-Cash-Flow | 34.33 | |||||
| Price-to-Operating-Cash-Flow | 11.5 | |||||
| EV-to-EBIT | -3.02 | |||||
| EV-to-EBITDA | -3.02 | |||||
| EV-to-Revenue | 2.45 | |||||
| EV-to-FCF | 52.43 | |||||
| Price-to-Projected-FCF | 2.1 | |||||
| Price-to-Median-PS-Value | 0.27 | |||||
| Earnings Yield (Greenblatt) % | -33.11 | |||||
| FCF Yield % | 2.13 | |||||
| Forward Rate of Return (Yacktman) % | 21.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chempartner Pharmatech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,104.302 | ||
| EPS (TTM) (Â¥) | -1.814 | ||
| Beta | 1.69 | ||
| Volatility % | 35.66 | ||
| 14-Day RSI | 40.26 | ||
| 14-Day ATR (Â¥) | 0.239713 | ||
| 20-Day SMA (Â¥) | 5.1455 | ||
| 12-1 Month Momentum % | -42.53 | ||
| 52-Week Range (Â¥) | 3.68 - 9.74 | ||
| Shares Outstanding (Mil) | 499.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chempartner Pharmatech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chempartner Pharmatech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chempartner Pharmatech Co Ltd Frequently Asked Questions
What is Chempartner Pharmatech Co Ltd(SZSE:300149)'s stock price today?
The current price of SZSE:300149 is ¥4.84. The 52 week high of SZSE:300149 is ¥9.74 and 52 week low is ¥3.68.
When is next earnings date of Chempartner Pharmatech Co Ltd(SZSE:300149)?
The next earnings date of Chempartner Pharmatech Co Ltd(SZSE:300149) is .
Does Chempartner Pharmatech Co Ltd(SZSE:300149) pay dividends? If so, how much?
Chempartner Pharmatech Co Ltd(SZSE:300149) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers